Skip to main content

Table 1 Estimated changes from baseline (0 h) to end of exposure (3½ h) and to 6 h for all the respiratory outcomes

From: Effects of wood smoke particles from wood-burning stoves on the respiratory health of atopic humans

 

Clean air

Low wood smoke exposure

High wood smoke exposure

  

Change (0 h-3½ h)

Change (0 h-6 h)

Change (0 h-3½ h)

Change (0 h-6 h)

Change (0 h-3½ h)

Change (0 h-6 h)

Variable category

Unit

Mean

(CI)

Mean

(CI)

Mean

(CI)

Mean

(CI)

Mean

(CI)

Mean

(CI)

Lung function

             

FEV1

Liters

−0.01

(−0.07 ; 0.05)

0.00

(−0.05 ; 0.06)

0.03

(−0.02 ; 0.09)

0.04

(−0.01 ; 0.10)

0.02

(−0.04 ; 0.07)

0.06

(0.00 ; 0.11)

FVC

Liters

0.05

(−0.09 ; 0.18)

0.04

(−0.09 ; 0.17)

0.02

(−0.11 ; 0.16)

0.05

(−0.08 ; 0.17)

0.13

(−0.01 ; 0.26)

0.15

(0.03 ; 0.27)

PEF

Liters/min

−18.45

(−34.93 ; -1.97)

−15.30

(−34.33 ; 3.73)

−9.69

(−25.75 ; 6.37)

−5.28

(−23.83 ; 13.27)

−11.39

(−27.10 ; 4.31)

−6.64

(−24.77 ; 11.49)

Fractional exhaled NO

             

FENO50

ppb NO

−2.14

(−4.07 ; -0.21)

N/A

N/A

−0.26

(−2.14 ; 1.63)

N/A

N/A

−1.60

(−3.48 ; 0.29)

N/A

N/A

FENO270

ppb NO

−0.38

(−0.95 ; 0.18)

N/A

N/A

0.07

(−0.48 ; 0.62)

N/A

N/A

−0.21

(−0.76 ; 0.34)

N/A

N/A

Exhaled breath condensate

             

Conductivity #

μS/cm

3.52

(−14.00 ; 21.03)

−5.54

(−142.94 ; 131.86)

−21.66

(−38.91 ; -4.42)

13.65

(−120.27 ; 147.57)

−2.80

(−19.75 ; 14.15)

−201.27

(−331.98 ; -70.57)

pH

 

0.25

(0.01 ; 0.50)

0.19

(−0.14 ; 0.51)

0.10

(−0.14 ; 0.33)

0.34

(0.03 ; 0.66)

0.02

(−0.23 ; 0.25)

−0.23

(−0.54 ; 0.08)

8-Isoprostane

pg/ml

0.12

(−4.38 ; 4.61)

−0.73

(−11.05 ; 9.58)

−6.16

(−10.54 ; -1.78)

−4.15

(−13.92 ; 5.62)

0.53

(−4.08 ; 5.14)

−7.40

(−16.95 ; 2.14)

Nasal lavage biomarkers

             

IL-1β

pg/ml

−1.41

(−4.81 ; 2.00)

0.19

(−2.83 ; 3.21)

0.35

(−2.97 ; 3.67)

0.85

(−2.10 ; 3.80)

−1.14

(−4.43 ; 2.14)

2.51

(−0.42 ; 5.44)

IL-6

pg/ml

6.62

(−0.41 ; 13.65)

2.39

(−5.69 ; 10.47)

−1.90

(−8.60 ; 4.80)

−8.10

(−15.85 ; -0.35)

5.42

(−1.14 ; 11.98)

5.48

(2.10 ; 13.06)

IL-8 #

pg/ml

0.86

(−3.63 ; 5.36)

2.92

(−1.89 ; 7.74)

2.40

(−1.92 ; 6.73)

0.70

(−3.93 ; 5.33)

−5.47

(−9.72 ; -1.22)

0.38

(−4.16 ; 4.92)

IL-12 #

pg/ml

1.20

(−0.81 ; 3.21)

−0.75

(−3.10 ; 1.61)

−0.80

(−2.71 ; 1.11)

−2.20

(−4.46 ; 0.06)

1.86

(−0.01 ; 3.73)

1.48

(−0.73 ; 3.69)

IL-18 #

pg/ml

−1.49

(−6.00 ; 2.63)

−6.00

(−10.64 ; -1.35)

−0.95

(−4.88 ; 2.98)

0.00

(−4.46 ; 4.46)

−3.21

(−7.06 ; 0.63)

−2.71

(−7.07 ; 1.66)

Nasal volume

             

VOl2-4 #

ml

0.20

(0.01 ; 0.39)

0.16

(−0.04 ; 0.35)

0.22

(0.03 ; 0.41)

0.20

(0.01 ; 0.39)

0.14

(−0.05 ; 0.32)

0.24

(0.05 ; 0.42)

  1. N/A (Not available, no measurement).
  2. #Estimates based on the modified mixed model (not including the random patient*expo).